Skip to content
Fly High Investing
Sign In
Company news2 min read

BMEZ (BlackRock Health Sciences Term Trust) Reports Oversubscribed Tender Offer

BlackRock Health Sciences Term Trust reported on November 18, 2026 that shareholders tendered far more shares than its repurchase offer could accept. The preliminary count was 13,178,845 shares against a limit of 3,125,070, so participating shareholders should expect only part of their submitted shares to be purchased.

The offer covered up to 5% of outstanding shares and expired on November 18. Accepted shares will be purchased at 98% of net asset value, the value of the fund’s assets after liabilities, measured at the November 19 market close. That means the dollar purchase price was still undetermined when these preliminary results were announced.

Dividing the repurchase limit by the preliminary tender count gives an indication of roughly 23.7% acceptance. That is our calculation from the announced figures, not the fund’s final allocation. BlackRock said the counts remain subject to adjustment and expects to announce final results, including the allocation percentage, on or about November 19.

For shareholders who remain, repurchasing shares below net asset value can modestly increase the asset value attributable to each remaining share before expenses, because the fund pays less than the underlying asset value it retires. The actual effect will depend on the final purchase price, accepted shares and costs. The oversubscription itself does not establish why holders tendered or predict where the market price will trade.

Our view is that this is a useful but limited capital action. It gives some shareholders an exit tied closely to asset value and can benefit the asset backing of those who remain, but it does not demonstrate stronger recurring earnings or improved distribution support. The next meaningful evidence is the final allocation and price, followed by whether the remaining portfolio generates the returns needed to sustain shareholder payments.

Sources

This article is general information, not personalized investment advice. Fly High Investing may hold securities discussed in this article.

Browse all news